Application Note
*Optimal dilutions/concentrations should be determined by the researcher.
Application |
Recommended Dilution |
1 - 5 μg/ml |
Assay dependent |
1 μg/ml |
Not tested in other applications.
Calculated MW
Positive Control
HepG2 cells
Product Note
This antibody recognizes the ~130 kDa α and the ~90 kDa β subunits of IGF-I receptor and is not suitable for use in IHC-P or WB.
Form
Liquid
Buffer
0.05M Sodium Phosphate buffer, 0.2% Gelatin
Preservative
0.1% Sodium azide
Storage
Store as concentrated solution. Centrifuge briefly prior to opening vial. Store at 4ºC. DO NOT FREEZE.
Concentration
0.1 mg/ml (Please refer to the vial label for the specific concentration.)
Antigen Species
Human
Immunogen
Immunogen used was partially purified receptor from human placenta.
Purification
Affinity purified with antigen
Conjugation
Unconjugated
RRID
AB_425129
Note
For laboratory research use only. Not for any clinical, therapeutic, or diagnostic use in humans or animals. Not for animal or human consumption.
Purchasers shall not, and agree not to enable third parties to, analyze, copy, reverse engineer or otherwise attempt to determine the structure or sequence of the product.
Synonyms
insulin like growth factor 1 receptor , CD221 , IGFIR , IGFR , JTK13
Cellular Localization
Cell membrane
Background
This receptor binds insulin-like growth factor with a high affinity. It has tyrosine kinase activity. The insulin-like growth factor I receptor plays a critical role in transformation events. Cleavage of the precursor generates alpha and beta subunits. It is highly overexpressed in most malignant tissues where it functions as an anti-apoptotic agent by enhancing cell survival. Alternatively spliced transcript variants encoding distinct isoforms have been found for this gene. [provided by RefSeq, May 2014]
Database
Research Area